Skip to main content
SpringerLink
Log in

Treatment of Oral Candida Mucositis Infections

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Infections due to Candida spp. are increasing in incidence as the number of immune compromised patients increases. The common presentation of Candida mucositis and oral infections includes atrophic candidiasis, angular cheilitis, leukoplakia and oesophagitis. An increasing spectrum of antifungal agents, including imidazoles, are available for treatment and suppression of this common infection. In chronically immune-compromised patients such as those with severe HIV related immune deficiency, eradication of the infection may not be possible. This requires a stepwise approach to management and may require the use of potent, toxic agents such as amphotericin B to suppress the symptoms and signs of infection sufficiently to provide the patient with symptomatic relief. Resistant organisms are also becoming a greater problem in this patient population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bonacini M, Young T, Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection: a prospective study of 110 patients. Archives of Internal Medicine 151: 1567–1572, 1991

    Article  PubMed  CAS  Google Scholar 

  • Crislip MA, Edwards Jr JE. Candida albicans and related species. In Gorbach et al. (Eds) Infectious diseases, pp. 1887–1889, WB Saunders Co., Philadelphia, 1992

    Google Scholar 

  • DeWit S, Goosens H, Weerts D, Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1: 746–748, 1989

    Article  CAS  Google Scholar 

  • Edwards Jr JE. Candida species. In Mandell et al. (Eds) Principles and practice of infectious disease, pp. 1943–1949, Churchill Livingstone Inc., New York, 1990

    Google Scholar 

  • Koletar SL, Russell JA, Fass RJ, Plouffe JF. Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with HIV. Antimicrobial Agents and Chemotherapy 34: 2267–2268, 1990

    Article  PubMed  CAS  Google Scholar 

  • Kowalsky SF, Dixon DM. Fluconazole: a new antifungal agent. Clinical Pharmacy 10: 179–194, 1991

    PubMed  CAS  Google Scholar 

  • Laine L, Conteus C, Islam MZ, et al. Prospective randomised double blind trial of fluconazole vs ketoconazole for Candida esophagitis. Gastroenterology 100: A591, 1990

    Google Scholar 

  • Laine L, Dretler RH, Conteas CN, et al. Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. Annals of Internal Medicine 117: 655–660, 1992

    PubMed  CAS  Google Scholar 

  • Lake-Bakaar G, Tom W, Lake-Bakaar D, et al. Gastropathy and ketoconazole malabsorption in AIDS. Annals of Internal Medicine 109: 471–473, 1988

    PubMed  CAS  Google Scholar 

  • Marriott DJE, Jones PD, Hoy JF, Speed BR, Harkness JL. Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV infected patients. Medical Journal of Australia 158: 312–316, 1993

    PubMed  CAS  Google Scholar 

  • McCloskey R, Hathorn J, Buell DN. Fluconazole vs. clotrimazole treatment of oropharyngeal candidiasis in adults with malignancy. Proceedings of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting, October 21-24,1990, Atlanta, Georgia, Abstract #1280,1990 Americal Society for Microbiology, Washington, DC, 1990

  • Petersen EA, Alling DW, Kirkpatrick CH. Treatment of chronic mucocutaneous candidiasis with ketoconazole. Annals of Internal Medicine 93: 791–795, 1980

    PubMed  CAS  Google Scholar 

  • Powderly WG, Saag MS, Cloud GA, et al. Controlled trial of fluconazole or amphotericin-B to prevent relapse of cryptococcal meningitis in patients with AIDS. New England Journal of Medicine 326: 793–798, 1992

    Article  PubMed  CAS  Google Scholar 

  • Shepp DH, Klosterman A, Siegel SM, et al. Comparative trial of ketoconazole and nystatin for the prevention of fungal infection in neutropenic patients treated in a protective environment. Journal of Infectious Diseases 152: 1257–1263, 1985

    Article  PubMed  CAS  Google Scholar 

  • Smith DE, Midgley J, Allan M, et al. Itraconazole vs ketoconazole in the treatment of oral and esophageal candidiasis in patients infected with HIV. AIDS 5: 1367–1371, 1991

    Article  PubMed  CAS  Google Scholar 

  • Thorsen S, Mathiesen LR. Fluconazole for ketoconazole resistant oropharyngeal candidiasis in HIV-1 infected patients. Scandinavian Journal of Infectious Disease 22: 275–276, 1990

    Article  Google Scholar 

  • Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei among patients with transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine 325: 1274–1277, 1991

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Ottawa General Hospital, University of Ottawa, 501 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada

    Gary E. Garber

Authors
  1. Gary E. Garber
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garber, G.E. Treatment of Oral Candida Mucositis Infections. Drugs 47, 734–740 (1994). https://doi.org/10.2165/00003495-199447050-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199447050-00003

Keywords

Search

Navigation